Ablynx

Ablynx, a Sanofi company, is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments, which combine the advantages of conventional antibody drugs with some of the features of small-molecule drugs. Ablynx is dedicated to creating new medicines which will make a real difference to society. Today, the company has more than 45 proprietary and partnered programmes in development in various therapeutic areas including inflammation, haematology, immuno-oncology, oncology and respiratory disease. The company has collaborations with multiple pharmaceutical companies including AbbVie; Boehringer Ingelheim; Eddingpharm; Merck & Co., Inc., Kenilworth, New Jersey, USA; Merck KGaA; Novo Nordisk and Taisho Pharmaceuticals. The company is based in Ghent, Belgium. More information can be found on www.ablynx.com.

See above.

We invite you to join our team and to explore the Job Opportunities section on our website (www.ablynx.com) to find the positions we are currently recruiting for.

Advance your career by joining the Ablynx team. Each day you will have the opportunity to contribute and to develop your skills and experiences in a young, fast moving and multicultural environment. At Ablynx, we embrace diversity, be it age:, gender, ethnicity, nationality, religion, or working and thinking style.

The working environment at Ablynx is innovative, focused and open with a great deal of independence within the job function. You will have the opportunity to work with an outstanding scientific and business team and contribute to the discovery and development of the next novel Nanobody drug. As a company, we strive to provide all our employees with the means to develop their skills and experiences, at any level, and this in an environment and atmosphere where having fun at work is a reality.